Arax Advisory Partners’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.7K Buy
389
+364
+1,456% +$25.6K ﹤0.01% 3636
2026
Q1
$1.43K Hold
25
﹤0.01% 3204
2025
Q4
$1.26K Sell
25
-433
-95% -$22.1K ﹤0.01% 3425
2025
Q3
$22.9K Buy
458
+443
+2,953% +$20.3K ﹤0.01% 2202
2025
Q2
$601 Buy
+15
New +$559 ﹤0.01% 2903
2025
Q1
Sell
-19
Closed -$743 2962
2024
Q4
$743 Sell
19
-60
-76% -$2.16K ﹤0.01% 2236
2024
Q3
$2.32K Hold
79
﹤0.01% 2010
2024
Q2
$2.44K Buy
+79
New +$2.5K ﹤0.01% 1896

Other funds holding PRLB

Arax Advisory Partners's PRLB Position: Q2 2026 in Review

Arax Advisory Partners increased its Protolabs (PRLB) stake by 1,456% in Q2 2026, buying an estimated $25.6K and bringing the position to 389 shares worth $31.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3636.

Arax Advisory Partners first reported a position in PRLB in Q2 2024 and has held it in 8 quarters since. 277 funds tracked by Wall St. Rank hold PRLB as of Q2 2026.

  • Arax Advisory Partners held 389 shares of Protolabs worth $31.7K as of Q2 2026.
  • Arax Advisory Partners bought 364 Protolabs shares in Q2 2026, an estimated $25.6K.
  • Protolabs made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3636 holding.
  • Arax Advisory Partners first reported a position in Protolabs in Q2 2024 and has held it in 8 quarters since.
  • 277 funds tracked by Wall St. Rank held Protolabs as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.